3 completed, 3 recruiting, 3 unknown. 3 Phase 3, 2 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Olanzapine: new trials by email Literature Review of Olanzapine trials Research Report on Olanzapine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors Pantoprazole, olanzapine, Dexamethasone - Olanzapine, Breast Cancer | Not applicable | Recruiting | Alexandria University | 90 | 2026-05-10 | 2026-08-04 |
| Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin dexamethasone sparing - Cancer (Solid Tumors), Vomiting | Phase 2 | Recruiting | Mahidol University | 95 | 2026-02-10 | 2026-07-13 |
| Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis Olanzapine (dose comparison: 2.5 mg, 5 mg, 10 mg) - Solid Tumours, Olanzapine | Completed | Shandong Cancer Hospital and Institute | 2493 | 2026-01-18 | 2026-09-09 | |
| Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer Olanzapine 2.5 MG, Standard anti-tumor treatment, Nutritional advice - Advanced Cancer, Olanzapine | Phase 3 | Recruiting | Qinghai Red Cross Hospital | 230 | 2024-03-20 | 2024-03-29 |
| HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet - Haloperidol, Advanced Cancer | Phase 3 | Completed | Tan Tock Seng Hospital | 22 | 2022-05-18 | 2026-10-05 |
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer Olanzapine Tablets, Placebo - Olanzapine, CINV | Phase 3 | Unknown | Shi Yanxia | 75 | 2022-01-18 | 2023-02-06 |
| Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Semaglutide, 1.34 mg/mL, Semaglutide-placebo - Metabolic Disturbance, Schizophrenia | Phase 4 | Unknown | Anders Fink-Jensen, MD, DMSci | 104 | 2021-09-01 | 2024-09-25 |
| Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Flupentixol, Multi-acting receptor-targeted antipsychotics (MARTAs) - Schizophrenia; Psychosis, Metabolic Syndrome | Phase 4 | Completed | Taichung Veterans General Hospital | 30 | 2019-12-19 | 2021-05-24 |
| Amisulpride Treatment for BPSD in AD Patients Amisulpride, Olanzapine - BPSD, Amisulpride | Not applicable | Unknown | Tianjin Anding Hospital | 76 | 2019-12-01 | 2022-11-16 |
Vomiting (3) · Nausea (2) · Schizophrenia (2) · Breast Neoplasms (1) · Central Nervous System Diseases (1) · Diabetes Mellitus, Type 2 (1) · Metabolic Syndrome (1) · Neoplasms (1) · Psychotic Disorders (1) · Testicular Neoplasms (1)
Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Signs and Symptoms, Digestive (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Mental Disorders (2) · Metabolic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Nutritional and Metabolic Diseases (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Breast Diseases (1) · Diabetes Mellitus (1) · Endocrine Gland Neoplasms (1) · Genital Diseases (1)
Olanzapine (5) · Amisulpride (1) · Dexamethasone (1) · Flupenthixol (1) · Haloperidol (1) · Pantoprazole (1) · Solutions (1) · semaglutide (1)
Alexandria University (1) · Anders Fink-Jensen, MD, DMSci (1) · Mahidol University (1) · Qinghai Red Cross Hospital (1) · Shandong Cancer Hospital and Institute (1) · Shi Yanxia (1) · Taichung Veterans General Hospital (1) · Tan Tock Seng Hospital (1) · Tianjin Anding Hospital (1)
China (4) · Denmark (1) · Egypt (1) · Singapore (1) · Taiwan (1) · Thailand (1)
Anders Fink-Jensen, MD (1) · Chia-Jui Tsai, M.D. (1) · Mervyn Koh (1) · Yanxia Shi, PHD (1)